Background: ADAS was designed to measure the severity of the most important symptoms of Alzheimer's disease (AD). Its subscale ADAS-cog is the most popular cognitive testing instrument used in clinical trials of nootropics. It consists of 11 tasks measuring the disturbances of memory, language, praxis, attention and other cognitive abilities which are often referred to as the core symptoms of AD.
View Article and Find Full Text PDFAccording to results of the census of gerontopsychiatric patients, on June 30, 1993 there were 741 hospitalized patients. In the submitted paper the authors follow up data on 207 patients treated with antidepressants. In 73% endogenous depressions were involved another third of the patients suffered from reactive conditions, organic mental disorders and dependence.
View Article and Find Full Text PDF